The effects of antisense AKT2 RNA on the Inhibition of malignant glioma cell growth in vitro and in vivo

Journal of Neuro-Oncology

Volumn 76, Issue 1, 2006, Pages 1-11

  Pu, Peiyu ^a   Kang, Chunsheng ^a   Li, Jie ^a   Jiang, Hao ^b   Cheng, Jinquan ^c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b HENRY FORD HOSPITAL   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Antisense AKT2; Apoptosis; Cell proliferation; Malignant gliomas

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; CYCLIN D; GELATINASE A; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; LIPOFECTAMINE; PROTEIN KINASE B BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN RADIOGRAPHY; CANCER INHIBITION; CANCER SURVIVAL; CARCINOGENESIS; CAUDATE NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; GENETIC ANALYSIS; GENETIC TRANSFECTION; GLIOMA; GLIOMA CELL; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION; RAT; SURVIVAL TIME; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL PROLIFERATION; DISEASE PROGRESSION; GLIOMA; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RNA; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 30944467414     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-3029-3     Document Type: Article

References (51)

1. RM Agosti M Leuthold WJ Gullick MG Yarsagil OD Wiester 1992 Expression of the epidermal growth factor receptor in astrocytic tumors is specially associated with glioblastoma multiforme Virchows Arch (A) Pathol Anat 420 321-325 1:STN:280:By2B3s%2FhvV0%3D
2. AJ Ekstrand CD James WK Cavence B Selliger RF Patterson VP Collins 1991 Genes for epidermal growth factor receptor, transforming growth factor α and epidermal growth factor and their expression in human gliomas in vivo Cancer Res 51 2164-2172 2009534 1:CAS:528:DyaK3MXisVWkurw%3D
3. Liu X, Pu P: Expression of epidermal growth factor receptor gene in human gliomas. J Neurochem 67(Suppl): S 11A (Abstract), 1996
4. JA Takahashi H Mori M Fukumoto K Igarashi M Jaye Y Oda H Kikuchi M Hatanaka 1990 Gene expression of fibroblast growth factors in human gliomas and meningiomas: Demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissue Proc Natl Scad Sci USA 87 5710-5714 1:CAS:528:DyaK3cXlsV2ktL8%3D
5. A Guha K Dashner PM Black JA Wagner CD Stiles 1995 Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop Int J Cancer 60 168-173 7829210 1:STN:280:ByqC3s%2Fit1I%3D
6. M Hermanson K Funa M Haartman L Claesson-Welsh CH Heldin B Westermark M Nister 1992 Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops Cancer Res 52 3213-3219 1317261 1:CAS:528:DyaK38Xkt1Cjsbw%3D
7. AC Sandberg-Nordqvist PA Stahlborn M. Reinecke VP Collins H Hoist von V Sara 1993 Characterization of insulin-like growth-factor I in human primary brain tumors Cancer Res 33 2475-2478
8. HN Antoniades T Galanlpoulos J Neville-Golden M Maxwell 1992 Expression of insulin-like growth factor I, II and their receptor mRNAs in primary human astrocytomas and meningiomas: In vivo studies using in situ hybridization and immunocytochemistry Int J Cancer 50 215-222 1370435 1:STN:280:By2C3M3js1M%3D
9. JR Hill N Kuriyama H Kuriyama MA Israel 1999 Molecular neuropathology of astrocytic brain tumors J Neuro-Oncol 56 439-441 1:STN:280:DyaK1M3htlChtg%3D%3D
10. R Wechsler-Reya MP Scott 2001 The development biology of brain tumors Annu Rev Neurosci 24 385-428 11283316 10.1146/annurev.neuro.24.1.385 1:CAS:528:DC%2BD3MXls1Shs78%3D
11. JR Testa A Bellacosa 2001 AKT plays a central role in tumorigenesis Proc Natl Scad Sci USA 98 10983-10985 1:CAS:528:DC%2BD3MXnt1yqsrY%3D
12. SR Datta A Brunet ME Greenberg 1999 Cellular survival: A play in three AKTs Genes Develop 13 2905-2927 10579998 1:CAS:528:DyaK1MXnvVCltLo%3D
13. KM Nicholson NG Anderson 2002 The protein Kinase B/Akt signaling pathway in human malignancy Cell Signal 14 381-395 11882383 10.1016/ S0898-6568(01)00271-6 1:CAS:528:DC%2BD38Xhs1ylsrs%3D 381-395
14. I Vivanco CL Sawyers 2002 The phosphotidylinositol-3-kinase-AKT pathway in human cancer Nat Rev Cancer 2 489-501 12094235 10.1038/nrc839 1:CAS:528:DC%2BD38XkvFKltLs%3D
15. MM Hill BA Hemmings 2002 Inhibition of protein kinase B/Akt: implications for cancer therapy Pharmacol Ther 93 243-253 12191616 10.1016/S0163-7258(02)00193-6 1:CAS:528:DC%2BD38XksVShurg%3D
16. MP Scheid JR Woodgett 2003 Unravelling the activation mechanism of protein kinase B/Akt FEBS Lett 546 108-112 12829245 10.1016/ S0014-5793(03)00562-3 1:CAS:528:DC%2BD3sXkvVKjs7k%3D
17. MB Martin TF Franke GE Stoica P Chambon BS Katzenellenbogen BA Stoica MS MoLemore SE Olivo A Stoica 2000 A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I Endocrinology 141 4502-4511
18. RC Musie-Helmericket HL Grimes A Bellacosa SE Malstrom PN Tsichlis N Rosen 1998 Cyclin D expression is controlled post-transcriptionally via a phosphotidylinositol 3-kinase/Akt dependent pathway J Biol Chem 273 29864-29872
19. LD Mayo DB Donner 2001 A phosphotidylinositol 3-kinase/Akt pathway promotes translocation of mdm2 from the cytoplasm to the nucleus Proc Natl Acad Sci USA 98 11598-11603 11504915 10.1073/pnas.181181198 1:CAS:528:DC%2BD3MXnt12js7s%3D
20. SS Kang T Kwon DY Kwon 1999 Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit J Biol Chem 274 13085-13090 10224060 1:CAS:528:DyaK1MXjtFOlsro%3D
21. D Kim S Kim H Koh S Yoon A Chung KS Cho J Chung 2001 Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production FASEB J 15 1953-1963 11532975 10.1096/fj.01-0198com 1:CAS:528:DC%2BD3MXntlGqt7c%3D
22. BK Park X Zeng RI Glazer 2001 Akt induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells Cancer Res 61 7647-7653 11606407 1:CAS:528:DC%2BD3MXnvFSht74%3D
23. T Kubiatowski T Jang MB Lachyankar R Salmonsen RR Nabi PJ Quesenberry NS Litofsky AH Ross LD Recht 2001 Association of increased phosphotidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas J Neurosurg 95 480-488 11565871 1:CAS:528:DC%2BD3MXmvFOjurg%3D
24. BJ Michell JE Griffiths KI Mitchelhill I Rodriguez-Crespo T Tiganis S Bozinovski PR Montellano de BE Kemp RB Pearson 1999 The Akt kinase signals directly to endothelial nitric oxide Curr Biol 9 845-848 10469573 10.1016/S0960-9822(99)80371-6 1:CAS:528:DyaK1MXltFChu74%3D
25. JQ Cheng AK Godwin A Bellacosa T Taguchi TF Franke TC Hamilton PN Tsichilis JR Testa 1992 AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas Proc Natl Acad Sci USA 89 9267-9271 1409633 1:CAS:528:DyaK3sXks12itbs%3D
26. QZ Yuan M Sun RI Feldman G Wang X Ma C Jiang D Coppola SV Nicosia JQ Cheng 2000 Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer Oncogene 19 2324-2330 10822383 10.1038/sj.onc.1203598 1:CAS:528:DC%2BD3cXjslelsLk%3D
27. A Bellacosa D deFeo AK Godwin DW Bell JQ Cheng DA Altomare M Wan L Dubeau 1995 Molecular alterations of the AKT2 oncogenes in ovarian and breast carcinomas Int J Cancer 64 280-285 7657393 1:CAS:528:DyaK2MXos1Gqsbw%3D
28. Y Liao R Grobholz U Abel L Trojan MS Michel P Angel D Mayer 2003 Increase of AKT/PKB expression correlates with Gleason pattern in human prostate cancer Int J Cancer 107 678-680 10.1002/ijc.11471
29. MD Ringel N Hayre J Saito B Saunier F Schuppert H Burch V Bernet KD Burman LD Kohn M Saji 2001 Overexpression and overactivation of Akt in thyroid carcinoma Cancer Res 61 6105-6111 11507060 1:CAS:528:DC%2BD3MXmt12ktLo%3D
30. JQ Cheng B Ruggen WM Klein WM Klein G Sonada DA Altomore DK Watson JR Testa 1996 Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA Proc Natl Acad Sci USA 83 3636-3641
31. T Mukohara S Kudoh S Yamauchi T Kimura N Yoshimura H Kanazawa K Hirata H Wanibuchi S Fukushima K Inoue J Yoshikawa 2003 Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell-lung-cancer (NSCLC) Lung Cancer 41 123-130 12871775 10.1016/S0169-5002(03)00225-3
32. H Nakayama T Ikebe M Beppu K Shirasuna 2001 High expression levels of nuclear factor κ, IkB kinase α, and Akt kinase in squamous cell carcinoma of the oral cavity Cancer 92 3037-3044 11753981 10.1002/ 1097-0142(20011215)92:12<3037::AID-CNCR10171>3.0.CO;2-# 1:CAS:528:DC%2BD38XjvVejsQ%3D%3D
33. M Sun G Wang JE Paciga RI Feldman ZQ Yuan X Ma SA Shelly R Jove PN Tsichilis SV Nicosia JQ Cheng 2001 AKT1/PKBα kinase is frequent elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells Am J Pathol 159 431-437 11485901 1:CAS:528:DC%2BD3MXms1Wisb8%3D
34. G Choe S Horvath TF Cloughsey K Crowsby D Seligson A Palotie L Inge BL Smith CL Sawyers PS Mischel 2003 Analysis of the phosphotidylinositol-3'-kinase signaling pathway in glioblastoma patients in vivo Cancer Res 63 2742-2746 12782577 1:CAS:528:DC%2BD3sXkt1aju7w%3D
35. RP Ermoian CS Furniss KR Lamborn D Basila MS Berger AR Gottschalk MK Nicholas D Stokoe DA Haas-Kogan 2002 Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival Clin Cancer Res 8 1100-1106 12006525 1:CAS:528:DC%2BD38XksVSqu7o%3D
36. J Schlegel G Piontek HD Mennel 2002 Activation of the anti-apoptotic Akt/ protein kinase B pathway in human malignant gliomas in vivo Anticancer Res 22 2837-2840 12530006 1:CAS:528:DC%2BD3sXosl2juw%3D%3D
37. Y Sonada T Ozawa KD Aldape DF Deen MS Berger RO Pieper 2001 Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma Cancer Res 61 6674-6678
38. P Pu X Liu A Liu JL Cui YT Zhang 2000 Inhibitory effects of antisense epidermal growth factor receptor RNA on the proliferation of rat C6 gliom cells in vitro and in vivo J Neurosurg 92 132-139 10616092 1:CAS:528:DC%2BD3cXmsVOgtw%3D%3D
39. TE VanMeter HK Roopai MM Kibble HL Fillmore WC Broaddus GJ Pilkington 2001 The role of matrix metalloproteinases genes in glioma cell invasion: Codependent and interactive proteolysis J Neuro-Oncol 53 213-215 10.1023/A:1012280925031 1:STN:280:DC%2BD3MnmvFyqsQ%3D%3D
40. JH Uhm NP Dooley JG Villemure VW Yong 1997 Glioma invasion in vitro: role of matrix metalloproteinases Can J Neurol Sci 24 3-15 9043741 1:STN:280:ByiC1MnmsFY%3D
41. DK Binder MS Berger 2002 Proteases and the biology of glioma cell invasion J Neuro-Oncol 56 149-158 10.1023/A:1014566604005
42. M Pekney C Eliasson CL Chien LG Kindblom R Liem A Hamberger C Betsholtz 1998 GFAP-deficient astrocytes are capable of stellation in vitro when cocultured with neurons and exhibits a reduced amounts of intermediate filaments and an increased cell saturation density Exp Cell Res 239 332-343
43. M Toda M Miura H Asou S Toya K Uyemura 1994 Cell growth suppression of astrocytoma C6 cells by glial fibrillary acidic protein CDNA transfection J Neurochem 63 1975-1978 7931355 1:CAS:528:DyaK2cXmsFaktrw%3D
44. Y Narita M Nagane K Mishima HJS Huang FB Furnari WK Cavenee 2002 Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphotidylinositol 3-K/Akt pathway in glioblastomas Cancer Res 62 6764-6769 12438278 1:CAS:528:DC%2BD38XovFOksbg%3D
45. NR Leslie CP Downes 2002 PTEN: The down side of PI3-Kinase signaling Cell Signal 14 285-295 11858936 10.1016/S0898-6568(01)00234-0 1:CAS:528:DC%2BD38Xhtleqtbc%3D
46. D Haas-Kogan N Shalev M Wong G Mills G Yount D Stokoe 1998 Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC Curr Biol 8 1195-1198 9799739 1:CAS:528:DyaK1cXntFWgsbg%3D
47. ML Sulis Parsons R Parsons 2003 PTEN: From pathology to biology Trends Cell Biol 13 478-483
48. AE Wakeling SP Guy JR Woodburn SE Ashtou BJ Curry AJ Burker KH Gibson 2002 ZD1839 (Iressa): An orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy Cancer Res 62 5749-5754 12384534 1:CAS:528:DC%2BD38XotFyktr8%3D
49. IW Tremont-Lukats MR Gilbert 2003 Advances in molecular therapies in patients with brain tumors Cancer Control 10 125-137 12712007
50. J Trojan BK Blossey TR Johnson SD Rudin M Tykocinski J Ilan J Ilan 1992 Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I Proc Natl Acad Sci USA 89 4874-4878 1594587 1:CAS:528:DyaK38XksVGlt7c%3D
51. J Trojan TR Johnson SD Rudin J Ilan ML Tykocinski J Ilan 1993 Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA Science 259 94-97 8418502 1:CAS:528:DyaK3sXptl2itw%3D%3D